SciLucent, Inc.
Nicole Lay, MS, DABT, is a seasoned expert in nonclinical safety and development, currently serving as the Director at SciLucent, Inc. since November 2021, after progressing from Associate Director and Senior Toxicology Consultant roles since 2014. With extensive experience in nonclinical program strategy, design, and management, Nicole has overseen trial-enabling studies and marketing strategies across various therapeutic indications, including oncology and cardiology. Prior to joining SciLucent, Nicole worked at MPI Research from 2006 to 2014, where roles included Study Coordinator and Project Leader, focusing on toxicology studies to support drug development. Nicole holds a Master’s degree in Pharmacology & Toxicology from Michigan State University and a Bachelor’s degree in Biology and Chemistry from Central Michigan University.
This person is not in any offices
SciLucent, Inc.
SciLucent provides FDA-focused regulatory, clinical, nonclinical, CMC, quality, scientific, and management consulting services to healthcare product companies that develop, manufacture and/or market pharmaceuticals, biopharmaceuticals, medical devices, combination products, and dietary supplement ingredients. Since 1998 we have provided our clients with innovative strategies and exceptional quality work products intended to enhance product development, approval, and marketing presence.